Comparison Overview
Lilly Brasil

Lilly Brasil
Av. Morumbi, 8264, São Paulo, BR
Last Update: 02/02/2026
A Lilly é líder mundial em saúde e há mais de um século une cuidado com descoberta para melhorar a vida de pessoas ao redor do mundo. A excelência, a integridade e o respeito pelas pessoas são valores inegociáveis e nos guiam em tudo o que fazemos. Nosso time de profi...

Glenmark Pharmaceuticals
Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099
Last Update: 29/04/2026
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...
Compliance Ranges Comparison

Lilly Brasil







Glenmark Pharmaceuticals






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Lilly Brasil in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
Glenmark Pharmaceuticals has 3.85% fewer incidents than the average of all companies with at least one recorded incident.
Incident History - Lilly Brasil (X = Date, Y = Severity)
Lilly Brasil cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)
Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Lilly Brasil

Glenmark Pharmaceuticals
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.